Current Strategies for Microbubble-Based Thrombus Targeting: Activation-Specific Epitopes and Small Molecular Ligands

Area of Science:

• Biomedical Engineering
• Nanotechnology
• Pharmacology

Background:

• Traditional free drug administration for thrombotic diseases lacks specificity.
• Active coagulation presents unique molecular targets (epitopes) on thrombi.
• Microbubbles offer a platform for enhanced ultrasound-mediated drug delivery.

Purpose of the Study:

• To review novel strategies for microbubble-based thrombus targeting.
• To explore the use of small molecular ligands for targeted delivery.
• To discuss challenges in translating these theranostic agents for thrombotic pathologies.

Main Methods:

• Review of recent scientific literature on microbubble targeting strategies.
• Analysis of small molecular ligands interacting with thrombus-specific epitopes.
• Discussion of epitope identification on activated platelets and fibrin.

Main Results:

• Small molecular ligands demonstrate high-affinity and selective targeting of thrombi.
• Microbubble agents can be engineered for site-specific delivery to clots.
• Targeting strategies leverage conformational and expressional changes during coagulation.

Conclusions:

• Microbubble-based agents show significant potential for targeted thrombus treatment and diagnostics.
• Small molecular ligands offer advantages over antibody-based strategies for thrombus targeting.
• Further research is needed to overcome challenges for clinical translation in thrombotic diseases.